The Next

When autonomous mobile robots (AMRs) support material movement within a multi-step biopharma process, equipment placement becomes a primary driver of performance. Strategically placed equipment stations and access points can enable big wins for your operations; however, a poorly planned layout will be a continuous challenge to your robot’s productivity and the ROI of your robotic investment.

For years, discussions around continuous bioprocessing have focused primarily on productivity, yield and process economics. While these factors remain important, today’s manufacturing leaders face a broader question: How realistically does process intensification influence the design, cost and long-term viability of an entire facility?

What makes innovation in life science labs possible? Breakthroughs are often attributed to bolt-of-lightning insights or lucky accidents. Serendipity does matter, but as Louis Pasteur famously noted, chance favors only the prepared mind. We can extend his idea further to say that chance also favors those who conduct research in a prepared lab.

Robots and Material Handling Equipment (MHE) can make a huge impact to biopharma productivity. But what should your fleet’s makeup and traffic flows look like to maximize efficiency and spend? Here’s how to ensure you’re getting the most out of your robotics and MHE investment.

Understand your operations, enable digital transformation, and transform your organization for lasting business improvements.

Every patient who receives a drug injection trusts that it’s safe. That trust depends on robust contamination control strategies built into the manufacturing process. Nowhere is this more important than during sterile filtration—the final step before drug products are filled into vials, syringes, or cartridges.

Life science construction is poised for expansion. That’s what we learned when we surveyed 500+ company leaders to understand their perspective on where the industry is going next: 86% predict healthy growth over the coming years.